Galmed Pharmaceuticals GLMD
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 3.92 | -2.32 | -2,044 | -2 | ||
| 2025Q4 | 6 | 31.76 | -3,042 | -5 | ||
| 2025Q3 | 11.04 | -2.64 | -2,095 | -2 | ||
| 2025Q2 | 14.72 | -5.04 | -2,109 | -2 | ||
| 2025Q1 | 11.52 | -4.96 | -1,264 | -1 | ||
| 2024Q4 | 25.52 | 289.24 | -1,644 | -3 | ||
| 2024Q3 | 54.88 | -18.48 | -2,011 | -2 | ||
| 2024Q2 | 26.4 | -13.2 | -1,222 | -1 | ||
| 2024Q1 | 33.24 | -16.8 | -1,401 | -1 | ||
| 2023Q4 | 43.68 | -2,151 | -2 | |||
| 2023Q3 | 59.52 | -329.28 | -1,468 | -1 | ||
| 2023Q2 | 287.04 | -91.2 | -1,871 | -2 | ||
| 2023Q1 | 614.16 | -103.68 | -2,002 | -2 | ||
| 2022Q4 | 720 | -11.95 | -2,449 | -3 | ||
| 2022Q3 | 447.98 | -306.29 | -5,380 | -5 | ||
| 2022Q2 | 936 | -216 | -3,730 | -4 | ||
| 2022Q1 | 2289.6 | -352.37 | -6,092 | -6 | ||
| 2021Q4 | 2620.8 | -7,492 | -7 | |||
| 2021Q3 | 4017.6 | -446.4 | -7,845 | -8 | ||
| 2021Q2 | 4377.6 | -475.2 | -8,412 | -8 |